Navigation Links
Cynosure Reports Second Quarter 2009 Financial Results
Date:7/28/2009

WESTFORD, Mass., July 28 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced financial results for the three months ended June 30, 2009.

Second Quarter 2009 Financial Results

Revenues for the three months ended June 30, 2009 were $20.8 million, compared with $39.2 million in the same period of 2008 and $14.8 million in the first quarter of 2009. The decline from the second quarter of 2008 reflected the ongoing global economic recession and the continued restrictive credit environment in the aesthetic laser industry. The increase from the first quarter of 2009 reflected a strengthening international market coupled with a slight improvement in the North American markets. Gross margin for the second quarter of 2009 was 58.0% of total revenues, compared with 67.1% for the same period of 2008 and 60.9% in the first quarter of 2009. The decline in gross margin in the second quarter of this year compared with the second quarter of 2008 and the first quarter of 2009 reflected a higher percentage of laser revenue from international distribution, where the company's products tend to have lower sales prices.

Cynosure reported a net loss for the second quarter of 2009 of $2.3 million, or $0.18 per basic and diluted share, compared with net income of $4.7 million, or $0.36 per diluted share, in the second quarter of 2008, and a net loss of $4.0 million, or $0.32 per basic and diluted share, in the first quarter of 2009.

"An increased contribution from international markets helped to offset the continued challenges in North America in the second quarter," said Cynosure's President and Chief Executive Officer Michael Davin.
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Cynosure Announces Presentations at Upcoming Investor Conferences
2. Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual Meeting
3. Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy
4. Cynosure Announces Schedule of Upcoming Investor Conferences
5. Cynosure Appoints H. Travis Lee as Vice President of Global Marketing
6. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
7. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
8. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
9. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
10. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
11. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotech fi...us, genomic data from the 1918 pandemic through th...t H1N1 pandemic, today issued its latest biochemic...the lethality of the H1N1 ("Swine Flu") virus has ... virus,s current outbreak in the spring of 2009 to...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportli...rt is available in its catalogue: ,, Brazil Bi..., http://www.reportlinker.com/p0165503/Brazil-B...ml ,, Brazil Bioethanol Market Analysis and Fo...rovides detailed analysis and forecasts of the glo...
(Date:11/24/2009)... The New York investment bank KTA C...U) has agreed an AU$6.7 mil convertible note priva...he private placement was arranged by KTA Capital a... , New York (PRWEB) Novemb... bank KTA Capital, LLC ("KTA Capital") h...
(Date:11/24/2009)... Health care employment grew by 2...nly one to show consistent growth during the U.S. ...s remain in trouble, and health systems are coming...l, instead of just administrators. , ...re employment continued growing in October despite...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
... DIEGO, Jan. 26 Gen-Probe Incorporated,(Nasdaq: ...ase its fourth,quarter and full year 2008 financia...mately 4:00 p.m. Eastern Time (ET). The announceme....m. ET. Hank Nordhoff, chairman and chief,executiv...t, finance, and,chief financial officer, will host...
...ELES, Jan. 26 De Novo Software(TM), a leading pro...nnounced today an agreement with BD Biosciences to...xpress(TM) -- to customers in clinical, research a...s, a segment of BD (Becton, Dickinson and Company)... and reagents. , , "We look forward to providing ...
... Calif., Jan. 26 AMDL, Inc. (NYSE Alternext US: A...tical company with operations in the U.S. and Chin...y financial guidance and first quarter business ob... AMDL reaffirms its fiscal year 2008 financial gui...d range of US$32 million to $36 million, which rep...
Other Biology Technology:Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2008 Earnings Conference Call 2BD Biosciences to Distribute FCS Express 2AMDL, Inc. Announces 2009 Financial Guidance and First Quarter Business Objectives 2AMDL, Inc. Announces 2009 Financial Guidance and First Quarter Business Objectives 3AMDL, Inc. Announces 2009 Financial Guidance and First Quarter Business Objectives 4AMDL, Inc. Announces 2009 Financial Guidance and First Quarter Business Objectives 5AMDL, Inc. Announces 2009 Financial Guidance and First Quarter Business Objectives 6
(Date:11/24/2009)...search on bacterial communities throughout six lar...poral patterns, suggesting that scientists could u...mate change in the polar regions. The study, publi... Academy of Sciences Early Edition, shows that ba...hronously over time, correlating with seasonal shi...
(Date:11/23/2009)... strain of the deadly superbug MRSAan infection-ca...sposes a far greater health threat than previously...ding to a study in the December issue of Emerging...ly picked up in fitness centers, schools, and othe...en of MRSA within hospitals, the report found. , ...
(Date:11/23/2009)... Society says that western lowland gorillas living...the "mother lode" of more than 125,000 gorillas di...ened by growing humans activity in the region. , ...sts adjacent to the southwest border of Lac Tl Com... high densities of the great apes still exist in t...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Tanning Beds as Harmful as Tanning in the Sun Reports Harvard Women 26apos 3Bs Health Watch 56061 1Tanning Beds as Harmful as Tanning in the Sun Reports Harvard Women 26apos 3Bs Health Watch 56061 2Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls 56057 1Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls 56057 2Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls 56057 3Lead Levels in Many Lipsticks Higher Than Reported 56053 1Lead Levels in Many Lipsticks Higher Than Reported 56053 2Lead Levels in Many Lipsticks Higher Than Reported 56053 3
...yone who studied a little genetics in high school ...e the A,T,G and C that make up the DNA code. But ...tics in the past decade has drawn attention to a f...etimes replaces cytosine in the famous DNA double ...ow there,s a sixth. In experiments to be publishe...
...rkeley -- Move over, Y chromosome it,s time X got...y of the chromosome associated with being female, ...s Bachtrog and her colleagues show that the histor...as the much-studied, male-determining Y chromosome...nefits of sexual reproduction. , "Contrary to the...
...T. PAUL, Minn. A first of its kind study examinin...ncy has found the drug appears to cause abnormal b...ished in the April 15, 2009, online issue of Neur...y of Neurology. , "Methamphetamine use is an in...leading to an increasing number of children with p...
Other Biology News:New nucleotide could revolutionize epigenetics 2New nucleotide could revolutionize epigenetics 3New nucleotide could revolutionize epigenetics 4The story of X -- evolution of a sex chromosome 2The story of X -- evolution of a sex chromosome 3The story of X -- evolution of a sex chromosome 4Prenatal meth exposure linked to abnormal brain development 2
VZV IgM ELISA Kit, Single from Bio-Quant Inc.
...tom siRNA service provides the premium quality siR...tom siRNAs can be readily ordered online by provid...roviding the sense and antisense siRNA sequences. ...lencer Pre-designed siRNAs, which are already desi...
Bovine Serum Albumin from Equitech-Bio
Rabbit Anti-MPV17 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: